These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32125042)

  • 21. IL-12p40 deletion reduces M1 macrophage polarization and alleviates cardiac remodeling via regulating Th17 cells differentiation, but not γδT 17 cells, in TAC mice.
    Pan H; Ji Q; Zhao M; Zheng Z; Lu X; Feng Y; Gan L; Ye J; Wan J; Ye D
    Eur J Pharmacol; 2024 Jul; 974():176602. PubMed ID: 38677538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NH
    Huang X; Liu Y; Yang X; Lai S; Zhang Y; Gu J; Li H; Xie Y; Xia Y
    Life Sci; 2019 Jun; 227():94-100. PubMed ID: 31004659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W; St Clair D; Butterfield A; Vore M
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity.
    Kobayashi M; Usui F; Karasawa T; Kawashima A; Kimura H; Mizushina Y; Shirasuna K; Mizukami H; Kasahara T; Hasebe N; Takahashi M
    Sci Rep; 2016 May; 6():26489. PubMed ID: 27225830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
    Zhang X; Zhu JX; Ma ZG; Wu HM; Xu SC; Song P; Kong CY; Yuan YP; Deng W; Tang QZ
    Int J Biol Sci; 2019; 15(3):556-567. PubMed ID: 30745842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-7 aggravates myocardial ischaemia/reperfusion injury by regulating macrophage infiltration and polarization.
    Yan M; Yang Y; Zhou Y; Yu C; Li R; Gong W; Zheng J
    J Cell Mol Med; 2021 Nov; 25(21):9939-9952. PubMed ID: 34581005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells.
    He Y; Yang Z; Li J; Li E
    Exp Mol Pathol; 2020 Apr; 113():104371. PubMed ID: 31917290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity.
    Zhao WJ; Wei SN; Zeng XJ; Xia YL; Du J; Li HH
    Toxicology; 2015 Jul; 333():76-88. PubMed ID: 25896364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1.
    Yuan YP; Ma ZG; Zhang X; Xu SC; Zeng XF; Yang Z; Deng W; Tang QZ
    J Mol Cell Cardiol; 2018 Jan; 114():38-47. PubMed ID: 29061338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
    Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
    Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress.
    Wang Z; Wang M; Liu J; Ye J; Jiang H; Xu Y; Ye D; Wan J
    Oxid Med Cell Longev; 2018; 2018():5179468. PubMed ID: 29682158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
    Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.
    Hu X; Li B; Li L; Li B; Luo J; Shen B
    Oxid Med Cell Longev; 2020; 2020():5347204. PubMed ID: 32509145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats.
    Zare MFR; Rakhshan K; Aboutaleb N; Nikbakht F; Naderi N; Bakhshesh M; Azizi Y
    Life Sci; 2019 Sep; 232():116623. PubMed ID: 31279781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.
    Zhu J; Zhang J; Zhang L; Du R; Xiang D; Wu M; Zhang R; Han W
    Biomed Pharmacother; 2011 Oct; 65(7):481-5. PubMed ID: 22000485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early biomarkers of doxorubicin-induced heart injury in a mouse model.
    Desai VG; C Kwekel J; Vijay V; Moland CL; Herman EH; Lee T; Han T; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):221-9. PubMed ID: 25448438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.